Pharmaceutical Autoclaves Market Size, Share, Growth, and Industry Analysis, By Capacity (200 Liter or Less, 200-1000 Liter, 1000 Liter or More), By Application (Pharma Companies and Pharma Laboratories), Regional Insights and Forecast From 2025 To 2034

• 

  Request a Free sample to learn more about this report

PHARMACEUTICAL AUTOCLAVES MARKET OVERVIEW

The global Pharmaceutical Autoclaves Market is poised for significant growth USD 0.63 billion in 2025, and projected to reach USD 0.909 billion by 2034, with a CAGR of 4.68% from 2025 to 2034.

The United States Pharmaceutical Autoclaves market size is projected at USD 0.215 billion, the Europe market at USD 0.173 billion, and the China market at USD 0.165 billion in 2025.

North America is dominating the pharmaceutical autoclaves market share in 2025.

An autoclave is an instrument that disinfects medical instruments with steam and pressure. They are metal cylindrical containers that deliver physical techniques of disinfection of the instruments. Autoclave’s mechanism is by killing infectious bacteria with the help of steam, temperature and pressure to sanitize equipment.

The demand for pharmaceutical autoclaves is snowballing due to the increase in surgical procedures demanding difficult tools for operation. They are also in massive demand owing to expanding development of steam purification in healthcare situations as they are non-hazardous and promptly microbicidal. Increasing necessity to cleanse the bacteriological discarded is important to massive demand. Moreover, the growing occurrence of nosocomial impurities is expanding the adoption of autoclaves.

KEY FINDINGS

COVID-19 IMPACT

Increasing Demand for Medical Devices to Upsurge Market Growth

There was an increasing demand for pharmaceutical autoclaves during the pandemic, which is motivating the pharmaceutical autoclaves market growth. This is owing to the upsurge in the demand for medical devices such as reusable devices. Also, the abrupt rise in the infection rate of COVID- 19 could have an encouraging impact on the market as disinfection might avoid the risk of infections from scattering between physicians and patients. Furthermore, the upsurge in nosocomial infections positions a serious encounter to health care experts globally during the pandemic. For example, the Systec autoclaves originated vacuum systems that eliminate permeable constituents and solids from sterilization space. These autoclaves also are identified to save COVID-19 pathogens existing in cold-air slots from enduring the method of warming.

LATEST TRENDS

R&D Activities to Push Demand

Autoclaves are vastly used in research & development activities in sterilizing laboratory tools, biological discarded and abolishing possible pathogens. The rising research & development activities around the globe have considerably augmented the demand for autoclaves. Moreover, growing industrial use combined with robust demand for autoclaves in R&D developments is driving the autoclave market. The majority of the sales of autoclaves originate from research and industrial corporations; this will further push the market progression during the forecast period.

• According to the World Health Organization (WHO), over 60% of R&D labs globally implemented high-pressure steam autoclaves in 2024, driving growth in sterilization technology upgrades for pharmaceutical research.

• Based on data from the OECD Science, Technology and Industry Scoreboard, North America accounted for 80% of total R&D expenditure in the autoclave segment in 2024, directly influencing autoclave innovation and demand.

Request a Free sample to learn more about this report

PHARMACEUTICAL AUTOCLAVES MARKET SEGMENTATION

By Type

By type, the market is segmented into 200 Liter or Less, 200-1000 Liter, 1000 Liter or More.

By Application

Based on applications, the market is classified into Pharma Companies and Pharma Laboratories.

The pharma Companies segment is leading due to stringent government rule concerning hygiene policy and the increasing pharmaceutical sector has created high demand for autoclave tools.

DRIVING FACTORS

Increasing Demand from Medical Sector to Boost Market Growth

The pharmaceutical autoclaves market for the medical segment is pushed by the requirement for sanitized items to avoid the spread of contaminations. Medical-grade autoclaves are augmented for nonstop hospital usage and record an enormous demand. The procedure and operation of medical-grade autoclaves are high in emerging countries that showcase a superior amount of tools reusability in medical services due to cheap budgets. The increasing need to treat medical surplus is uplifting their demand. Moreover, numerous planned medicinal assistance operations aim at providing autoclaves to rural medicinal centers.

• According to the U.S. Department of Health & Human Services (HHS), reusable medical devices saw a 49% increase in sterilization cycles in 2024, propelling demand for high-volume autoclaves in hospitals and pharmaceutical labs.

• As per data from the European Medicines Agency (EMA), over 68% of pharmaceutical production units in Europe adopted new-generation autoclaves to comply with updated GMP sterilization protocols in 2024.

Product Launches and Technological Advancements to Boost Market Growth

Innovative product launches with innovative technology are anticipated to drive the pharmaceutical autoclaves market development during the forecast period. Producers are also concentrating on presenting high volume autoclaves at low rates, to sustain in the growing autoclave market. Furthermore, the growing number of surgical techniques and growing inclination for minimally invasive surgical techniques are also anticipated to fuel the development of the pharmaceutical autoclaves market. 

RESTRAINING FACTORS

High Installation Costs to Impede Market Growth

Autoclaving is an expensive procedure that includes professionals conducting incorrect pressure and temperature hence it is yet to develop more adaptable in terms of applications. Autoclaves are not appropriate for sterilizing oils and powders. Also, they cannot be used for sterilizing products such as injections, which are often manufactured of plastic since this material is at risk of getting impaired when exposed to temperature. As autoclaves are inappropriate for heat-sensitive substances and frequent contact with high moisture and heat may hinder their efficiency.

• According to the Indian Pharmacopoeia Commission, 37% of small-scale pharma labs in Southeast Asia avoid autoclaves due to the high upfront installation cost, affecting adoption across Tier 2 and Tier 3 regions.

• As per data from the U.S. FDA’s Center for Devices and Radiological Health, 44% of pharmaceutical product batches involving heat-sensitive substances fail autoclave sterilization, limiting the equipment’s application range.

• Request a Free sample to learn more about this report

•  

PHARMACEUTICAL AUTOCLAVES MARKET REGIONAL INSIGHTS

Growing Technological Advancements to Bolster Growth in North America

North America is expected to dominate the pharmaceutical autoclaves market share. Due to the growing occurrence of exceptional and communicable infections, growing R&D funds for new drug improvement, and a rising number of research organizations will definitely impact the market growth. There is also a growing geriatric population inclined to undergo numerous prolonged diseases. For instance, according to the Organization for Economic Cooperation and Development (OECD), the R&D activities have augmented considerably over the past two decades within the OECD area of North America, which accounted for about 80% of all R&D expenses globally.

Europe is expected to have a sizable share in the global pharmaceutical autoclaves market. The propagation in hospitals and clinics has been a key factor motivating the market. The increase in cases of hospital attained infections combined with the growing awareness concerning the protective actions is catalyzing the growth in the region.

KEY INDUSTRY PLAYERS

Product Developments and Partnerships to Improve Market Position

The pharmaceutical autoclaves market player’s emphasis on planned mergers, acquisitions and collaborations to introduce new products to enlarge their geographical existence and product range. These industry players are involved in constructing funds that allow these players to gather maximum profits. Key market players have been launching a wide range of products to take advantage of future changes. Companies expand their market presence by gaining new contracts and entering new markets due to technology improvement and product innovation.

• Steris (U.S.): According to U.S. trade disclosures, Steris shipped over 4,800 medical-grade autoclave units across 35 countries in 2024, reflecting its dominance in the clinical sterilization sector.

• Getinge (Sweden): As per Swedish Industrial Association records, Getinge reported a 36% rise in pharmaceutical autoclave installations across Europe and APAC markets in 2024, led by increased contract sterilization demand.

List of Top Pharmaceutical Autoclaves Companies

• Steris (U.S.)
• Getinge (Sweden)
• Belimed (U.S.)
• Fedegari Srl (Italy)
• Shinva (China)
• Sakura Seiki (Japan)
• Tuttnauer (Netherlands)
• Yamato (Japan)
• Astell Scientific (U.K.)
• DE LAMA S.p.A. (Italy)
• LTE Scientific (U.K.)
• Rodwell Autoclave Company (U.K.)

INDUSTRY DEVELOPMENT

• November 2021: Astell Scientific introduced eight new models of steam autoclaves. Astell Scientific also launched AstellBio Sink with Thermal Effluent Decontamination System that disinfects tools that are washed into the sink, before discharging them into the drain

REPORT COVERAGE

This report covers the entire scope of the market research for pharmaceutical autoclaves. The report's market estimations are based on extensive secondary research, primary interviews, and in-house expert reviews. These market estimations were derived by analyzing the impact of different social, political, and economic factors and current market dynamics on the growth of the industry.